| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,912 |
2,838 |
$194K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,067 |
1,646 |
$19K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
307 |
226 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
509 |
364 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
607 |
534 |
$6K |
| 99051 |
|
410 |
313 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
423 |
301 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
575 |
392 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
30 |
26 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$474.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
12 |
$234.64 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20 |
14 |
$101.01 |
| 36415 |
Collection of venous blood by venipuncture |
49 |
38 |
$97.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
67 |
54 |
$85.70 |
| 86308 |
|
17 |
15 |
$83.34 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
150 |
126 |
$42.79 |
| 81003 |
|
19 |
12 |
$29.12 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
446 |
309 |
$2.10 |
| 36416 |
|
33 |
26 |
$0.00 |
| 99000 |
|
17 |
12 |
$0.00 |
| 99072 |
|
699 |
482 |
$0.00 |